The Department of Molecular and Medical Pharmacology (DMMP) is a combined basic science and clinical department. The DMMP integrates mathematics, engineering, physical, biological and medical sciences to achieve together advances that we cannot achieve individually in three overall areas: (1) understanding biology of disease, (2) developing new molecular diagnostics and (3) developing new molecular and cellular therapeutics.
The DMMP offers an opportunity for students, postdocs, medical fellows, and basic and clinical faculty to explore together the molecular and biological mechanisms that regulate cellular and organ functions to (1) identify and understand molecular errors of disease, (2) develop means to diagnose and monitor disease, and (3) develop pharmacological means to correct these errors. Within the DMMP are the preclinical Crump Institute for Molecular Imaging (CIMI) and the Ahmanson Translational Imaging Division (ATID). Within ATID, with its Nuclear Medicine and PET imaging research and clinical service, students have access to state-of-the-art science and technology to directly impact patient care.
Crump Institute for Molecular Imaging and DGSOM Seminar: Guillem Pratx, Ph.D., "The power of positrons: New approaches for cancer imaging", 11:00 am
Crump Institute for Molecular Imaging faculty member Jennifer M. Murphy, Ph.D., nominated by SNMMI as part of "Ones to Watch - Early Career Professionals Making a Difference in 2019"
Position opening: Postdoctoral Scholar position in Molecular Imaging